Effect of Omega Fatty Acids on treatment of Gastric Cancer

Evaluation of the effect of polyunsaturated fatty acids on the level of genes and Proteins of MMP1 , MMP9 , PDCD4 in gastric mucosal tissue in patients with gastric adenocarsinoma under chemotherapy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016121216922N2

Enrollment

Registered

2017-01-24

Start date

2015-07-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Adenocarsinoma. Malignant neoplasm of body of stomach

Interventions

Intervention 1: The second group oxaliplatin drug with pills Natural Factors Ultimate-Omega Factors 1200 mg of omega-3 fatty acid, omega-6 and Omega-9 to the formula: Fish Oil Blend 400 mg, Flexseed O

Treatment - Drugs

The second group oxaliplatin drug with pills Natural Factors Ultimate-Omega Factors 1200 mg of omega-3 fatty acid, omega-6 and Omega-9 to the formula: Fish Oil Blend 400 mg, Flexseed Oil 400 mg, Borag

In two groups to,The first group of patients was treated with oxaloplatin without prescription of omega fatty acids for three course, and each course includes three weeks .

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with gastric adenocarcinoma who that the chemotherapy will be. Exclusion criteria: People who are not taking medication due to cardiac obstruction; Pyloric obstruction due to people who are not able to take medicine; Diabetic patients; Patients with renal failure; Three months before entering the study, patients who are taking omega supplements.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Drug resistance. Timepoint: before and after. Method of measurement: jen expression and level of protein.	—

Secondary

Measure	Time frame
Oxidative stress. Timepoint: before and after. Method of measurement: jen expression and level of protein.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehran Khojastefard

Faculty of Medicin, Tabriz University

khojastefard63@gmail.com+98 413364672

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026